Explore
Validate
LearnMA5-26731
antibody from Invitrogen Antibodies
Targeting: TGFBI
BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1
Western blot
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-26731 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- TGFBI Monoclonal Antibody (OTI9A11)
- Antibody type
- Monoclonal
- Antigen
- Recombinant protein fragment
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- OTI9A11
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.
Kemper M, Schiecke A, Maar H, Nikulin S, Poloznikov A, Galatenko V, Tachezy M, Gebauer F, Lange T, Riecken K, Tonevitsky A, Aigner A, Izbicki J, Schumacher U, Wicklein D
Journal of experimental & clinical cancer research : CR 2021 Jun 26;40(1):214
Journal of experimental & clinical cancer research : CR 2021 Jun 26;40(1):214
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 6 Representative images of immunohistochemical staining of ITGAV, ITGB1, ITGB6, Ki-67, CEACAM7, TFBR1, pSMAD2, pSMAD2, TGFBI, Twist, E-cadherin, CD44, total and human fibronectin, STAT1 and HLA-DR ( a ) and quantification ( b ). The shown images are representative of three tumors harvested
